House Adds Device Adverse Events To Trial Registry Requirements
This article was originally published in The Gray Sheet
Executive Summary
Serious or frequent adverse events that occur during certain medical device clinical trials will need to be posted on a government Web site under a bill passed July 30 by the House
You may also be interested in...
Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon
Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20
Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon
Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20
FDA Technical Corrections Bill Could Address Trial Registry Requirements
Clinical trial registry requirements contained in the recently enacted FDA Amendments Act are likely to be clarified in a "technical corrections" bill in the coming weeks, device industry lobbyists say